Welcome to LookChem.com Sign In|Join Free

CAS

  • or

116983-17-6

Post Buying Request

116983-17-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

116983-17-6 Usage

Chemical structure

The compound contains a pyridine ring with two methyl groups at the 2nd and 6th positions, a nitrophenyl substituent at the 4th position, and two carboxylic acid groups at the 3rd and 5th positions.

Monoisopropyl ester

One of the carboxylic acid groups is attached to an isopropyl group, making it a monoester.

Potential applications

The compound has potential uses in the pharmaceutical industry and organic synthesis.

Suitability

Depending on the context, the compound may have properties and activities that make it suitable for use as a drug or as an intermediate in the production of other organic compounds.

Variation in properties

The specific uses and properties of the compound may vary depending on the context in which it is being utilized.

Nitro group

The presence of a nitro group (-NO2) in the compound may contribute to its reactivity and potential applications.

Hydrogenation

The 1,4-dihydro prefix indicates that the compound has undergone hydrogenation, which may affect its chemical properties and reactivity.

Dimethyl substitution

The presence of two methyl groups at the 2nd and 6th positions of the pyridine ring may influence the compound's steric properties and reactivity.

Carboxylic acid groups

The two carboxylic acid groups at the 3rd and 5th positions can participate in various chemical reactions, such as esterification, amidation, and formation of salts.

Nitrophenyl substituent

The 3'-nitrophenyl group attached to the 4th position of the pyridine ring may contribute to the compound's electronic properties and reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 116983-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,9,8 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 116983-17:
(8*1)+(7*1)+(6*6)+(5*9)+(4*8)+(3*3)+(2*1)+(1*7)=146
146 % 10 = 6
So 116983-17-6 is a valid CAS Registry Number.

116983-17-6Downstream Products

116983-17-6Relevant articles and documents

Noncovalently Functionalized Commodity Polymers as Tailor-Made Additives for Stereoselective Crystallization

Wan, Xinhua,Wang, Zhaoxu,Ye, Xichong,Zhang, Jie

supporting information, p. 20243 - 20248 (2021/08/09)

Stereoselective inhibition of the nucleation and crystal growth of one enantiomer aided by “tailor-made” polymeric additives is an efficient method to obtain enantiopure compounds. However, the conventional preparation of polymeric additives from chiral monomers are laborious and limited in structures, which impedes their rapid optimization and applicability. Herein, we report a “plug-and-play” strategy to facilitate synthesis by using commercially available achiral polymers as the platform to attach various chiral small molecules as the recognition side-chains through non-covalent interactions. A library of supramolecular polymers made up of two vinyl polymers and six small molecules were applied with seeds in the selective crystallization of seven racemates in different solvents. They showed good to excellent stereoselectivity in yielding crystals with high enantiomeric purities in conglomerates and racemic compound forming systems. This convenient, low-cost modular synthesis strategy of polymeric additives will allow for high-efficient, economical resolution of various racemates on different scales.

Syntheses, calcium channel antagonist and anticonvulsant activities of substituted 1,4-dihydro-3,5-pyridinedicarboxylates containing various 3-alkyl ester substituents

Yiu, Sai-Hay,Knaus, Edward E.

, p. 35 - 43 (2007/10/03)

A group of 3-alkyl-5-isopropyl 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates 10-20 containing an amine, quaternary ammonium, aryl(heteroaryl)alkenyl, 4-(4-fluorophenyl)-piperazin-1-yl or methoxy moiety in the C-3 alkyl ester R-substituent in combination with a C-4 phenyl ring bearing a 2,3-Cl2, 3-NO2, 3-NMe2, 4-NMe2 or 3,4,5-(OMe)3 X-substituent were prepared using the Hantzsch 1,4-dihydropyridine reaction. In vitro calcium channel antagonist activity (CCA) was determined using a guinea pig ileum longitudinal smooth muscle assay. In the C-4 3-nitrophenyl series of compounds, the C-3 ester R substituent was a determinant CCA activity where the relative potency order was -CH2CH2CH=C-(2-methylphenyl)2 ≤ -CH2CH2NMe2.HCl > -CH2CH2CH=C (3-methyl-2-thienyl)2 > -CH2CH2+NMe3I-. The position and nature of the C-4 phenyl X-substituent, were also determinants of CCA activity where the relative activity order was 3-NMe2>4-NMe2>3,4,5-(OMe)3. Anticonvulsant activities were determined in mice using the subcutaneous metrazol (scMet) and maximal electroshock (MES) screens. The compounds investigated were generally not effective for protecting against scMet induced seizures, except for 10 {X = 2,3-Cl2, R = 2-[4-(4-fluorophenyl)piperazin-1-yl]ethyl} and 14a (X = 3-NMe2.HCl, R = CH2CH2OMe), which exhibited modest activity. Compound 11a (X = 3-NO2, R = -CH2CH2NMe2.HCl) was the most effective agent in the MES screen. All of the compounds investigated, except for 11b (X = 3-NO2, R = -CH2CH2+NMe3 I-, Kp = 0.15) are lipophilic with n-octanol/aqueous phosphate buffer (pH = 7.4) partition coefficients (Kp) in the 121-424 range relative to the reference drug nimodipine (Kp = 187). The structure-activity relationship acquired reinforce the concept that calcium is only one of several factors that are involved in seizure generation.

Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position

Ogawa,Nakato,Tsuchida,Hatayama

, p. 108 - 116 (2007/10/02)

The synthesis of a new series of dihydropyridines containing a nitrooxy moiety at the 3-ester position is described. The antihypertensive activity of the compounds was examined and compared with that of nifedipine; some of them were relatively potent. The structure-activity relationship is also discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116983-17-6